DAVID HOLMES: Open Payments
NPI 1528583325 · WATERFORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 25 payments from 9 companies in 2025. Trend: 2023 $262 · 2024 $302 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 11 | $205 |
| Janssen Pharmaceuticals, Inc | 4 | $81 |
| ABBVIE INC. | 3 | $71 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Alkermes, Inc. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: SUBLOCADE, INVEGA SUSTENNA, VRAYLAR, UZEDY, ARISTADA, ABILIFY MAINTENA, COBENFY, CAPLYTA.
Industry payments across MI — which companies pay providers there.
